![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Grants ANDA for Breckenridge’s Rizatriptan Benzoate Tablets
FDA Grants ANDA for Breckenridge’s Rizatriptan Benzoate Tablets
January 1, 2013
The FDA has approved Breckenridge Pharmaceutical’s ANDA for rizatriptan benzoate tablets.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
21Oct